Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 512 (114th)

DISARM Act of 2015

referredUnited States· United States Congress· EN

Introduced

22 January 2015

Last action

5 February 2015 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Roskam, Peter J. [R-IL-6], Rep. Davis, Danny K. [D-IL-7], Rep. Lieu, Ted [D-CA-36], Rep. Kelly, Mike [R-PA-16], Rep. Buchanan, Vern [R-FL-16], Rep. Payne, Donald M., Jr. [D-NJ-10], Rep. Ellmers, Renee L. [R-NC-2], Rep. Pascrell, Bill, Jr. [D-NJ-9], Rep. Boustany, Charles W., Jr. [R-LA-3], Rep. Sánchez, Linda T. [D-CA-38], Rep. Bucshon, Larry [R-IN-8], Rep. Meehan, Patrick [R-PA-7], Rep. Sensenbrenner, F. James, Jr. [R-WI-5]

Subjects

Healthcare, Taxation

Source updated

12 August 2025

Healthcare · Taxation

Summary

Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2015 or the DISARM Act of 2015 Amends title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services to: (1) recognize the costs of DISARM antimicrobial drugs under the Medicare payment system for the inpatient services of subsection (d) hospitals, (2) provide for additional payment with respect to discharges involving such drugs, (3) publish in the Federal Register a list of the DISARM antimicrobial drugs, and (4) make a proportional adjustment in standardized payment amounts to assure that the requirements of this Act do not result in aggregate payments greater or less than those that would otherwise be made for a fiscal year. (Generally, a subsection [d] hospital is an acute care hospital, particularly one that receives payments under Medicare's inpatient prospective payment system [IPPS] when providing covered inpatient services to eligible beneficiaries.) Defines a "DISARM antimicrobial drug" as one approved or licensed by the Food and Drug Administration on or after January 1, 2015, which, among other things, is intended to treat an infection: caused by, or likely to be caused by, a qualifying pathogen; associated with high rates of mortality or significant patient morbidity; and for which there is an unmet medical need. Requires that the mechanism established by the Secretary to recognize the costs of new medical services and technologies that are not DISARM antimicrobial drugs under the Medicare payment system is applicable to new medical services or technology if the service or technology is not a DISARM antimicrobial drug. Directs the Comptroller General to study the barriers that prevent the development of DISARM antimicrobial drugs and develop recommendations for actions to be taken in order to overcome those barriers.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 22 January 2015

    Introduced

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 22 January 2015

    Introduced

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 22 January 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 22 January 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 23 January 2015

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  6. 5 February 2015

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 22 January 2015

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 22 January 2015

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 22 January 2015

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.